The pharmaceutical industry in some ways can be seen as rather cyclical. New diseases are discovered, new cures are discovered, the cures are patented, the drugs are sold, the profits go up, the patents expire, the generics come forth, the profits die down. The cycle...
Visa ($V) or Mastercard ($MA) ?
May 18, 2018 | Economics, Research
Sure, there's nothing like a crisp $ 100 bill, but at the end of the day it has to all go digital. The last couple of years have prompted lot's of discussion about cryptocurrency used in payment processing solutions that will dissolve the current credit card market....
Emerging Markets Private Equity and Venture Capital
May 4, 2018 | Economics, Research
When developed markets become over-saturated many institutional investors turn their attention towards emerging markets. International exchanges host a myriad of companies that may seem completely alien to most investors, however the bulk of the regional business...
Russian Stocks Amid Sanctions – Should Investors Turn to Yandex?
Apr 17, 2018 | Economics, Politics
Overview The Moscow Stock Exchange (MOEX) has historically shown a propensity to fluctuate heavily while under pressure. Whether sanctions, inflation, or politics is concerned - the exchange and its traded assets tend to be very sensitive. Following the announcement...
Tesla – Bears Could Cover at the Bottom
Mar 28, 2018 | Economics, Research
Tesla has a been a hot topic company over the last couple of years, praised for bringing revolutionary change to the automotive sector with their sleek cars, sexy marketing, and glorified CEO - Elon Musk. However, despite having developed a cult-like following that...